Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Since its discovery in 1984 by Svetlana Mosjov, GLP-1 and its analogs (such as semaglutide ... Exenatide and exendin-4 showed similar benefits in animal studies, enhancing populations of ...

A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

The phase 3 trial success over Lilly’s Trulicity (dulaglutide), an already-marketed GLP ... loss of 4.6 kg compared to 2.3 kg with 0.75 mg dulaglutide. People treated with 1.0 mg semaglutide ...

This between-group difference produced an estimated treatment ratio of 1.13 for semaglutide (95% CI 1.06-1.21), corresponding, in absolute terms, to a median 26.4-meter improvement in maximum ...

Please provide your email address to receive an email when new articles are posted on . The large-scale study focused on use of semaglutide and non-GLP-1 RAs. An increased risk for nonarteritic ...

Benefits for Moderation and Abstinence Goals GLP-1 receptor agonists like semaglutide and tirzepatide ... The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol-mediated behaviors ...